Status:

RECRUITING

Virtual Patient Navigation During a Pandemic

Lead Sponsor:

Children's Hospital of Philadelphia

Collaborating Sponsors:

National Institute of Mental Health (NIMH)

Conditions:

Post-partum Depression

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

The sub-study will involve a rigorous mixed-methods design. The qualitative phase of the sub-study will consist of semi-structured interviews. During the semi-structured interviews, 10 eligible women ...

Detailed Description

In the qualitative phase of the sub-study, 10 participants who are either former participants from the R61 Phase (IRB 19-016174) of the Main Randomized Clinical Trial (RCT), or have been referred, are...

Eligibility Criteria

Inclusion

  • Inclusion Criteria
  • Qualitative Phase:
  • Women who:
  • Are either former participants from the R61 Phase (IRB 19-016174) of the Main RCT, or have been referred, are actively enrolled, or withdrawn from the R33 Phase (IRB 22-019784) of the Main RCT.
  • Are \> 18 years of age
  • Speak and read in English
  • Have access to a smart phone or computer tablet with internet access
  • Have an infant \< 12 months of age
  • Intervention Phase:
  • Women who:
  • Are not actively engaged with MH services
  • Screen positive for postpartum depression (score\>9) on the EPDS
  • Are \> 18 years of age
  • Speak and read in English
  • Have access to a cellular phone with texting capabilities
  • Exclusion Criteria
  • Qualitative Phase:
  • Women who:
  • Report suicidality (i.e., suicidal ideation and/or behavior) on the EPDS (Question #10) at enrollment.
  • Report severe depressive symptoms (EPDS\>20) at enrollment.
  • Have a substantiated report of child maltreatment
  • Children who:
  • Were born premature (estimated gestational age\<35 weeks)
  • Have been diagnosed with congenital malformations or genetic syndromes which place them at risk of developmental delays
  • Are already currently receiving early intervention services for developmental delays at baseline
  • Intervention Phase:
  • Women who:
  • Report suicidality (i.e., suicidal ideation and/or behavior) on the EPDS (Question #10) with a response of "sometimes," or "yes, quite often" at participating pediatric practice
  • Report suicidality (i,e, suicidal ideation and/or behavior) on the EPDS (Question #10) and also endorse any of the follow up questions at a participating pediatric practice:
  • i. Have you ever felt that life is not worth living? ii. Has this feeling occurred in the past week? iii. Have you ever wanted to kill yourself? iv. Did you ever make a plan to kill yourself? v. Have you ever attempted suicide?
  • Have a substantiated report of child maltreatment

Exclusion

    Key Trial Info

    Start Date :

    June 29 2023

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    June 1 2026

    Estimated Enrollment :

    40 Patients enrolled

    Trial Details

    Trial ID

    NCT06208852

    Start Date

    June 29 2023

    End Date

    June 1 2026

    Last Update

    January 9 2026

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania, United States, 19104